2nd Annual TGH Liver Symposium
The symposium will highlight the latest treatment options on viral hepatitis; end stage liver disease; alcoholic liver disease; auto-immune disease; primary biliary cirrhosis; non-alcoholic steatohepatitis (NASH); bariatric surgery; oncology updates on hepatocellular carcinoma (HCC); update on TGH Commission on Cancer (CoC) designation; interventional radiology updates; hepatobiliary surgical cases; liver transplant updates; transplant coordinator and patient perspectives on the transplant process; advanced gastrointestinal endoscopy in liver disease; and palliative treatment in liver disease.
*Topics subject to change
Target Audience
Gastroenterologists, Surgeons, Oncologists, PCPs, and Infectious Disease Specialists, including MDs, ARNPs, PAs and RNs.